Senl_H19x22P / Avalon GloboCare  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Senl_H19x22P / SenlangBio
NCT04626765: CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Recruiting
1
50
RoW
CD19 CAR-T, Senl_19, CD22 CAR-T, Senl_22, CD 19+22, Senl_19+22, Fludarabine, flu, Cyclophosphamide, ctx
Hebei Senlang Biotechnology Inc., Ltd., The Second Hospital of Hebei Medical University
Childhood Acute Lymphoblastic Leukemia
03/23
05/23
NCT04626739: CAR-T Cells in Treating Patients With Relapsed or Refractory NHL

Recruiting
1
100
RoW
CD19 CAR-T, Senl_19, CD22 CAR-T, Senl_22, CD19+CD22 CAR-T, Senl_19+22, Fludarabine, flu, Cyclophosphamide, ctx
Hebei Senlang Biotechnology Inc., Ltd.
Refractory Indolent Adult Non-Hodgkin Lymphoma
03/23
03/23
NCT04626726: Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting
1
50
RoW
CD19 CAR-T, Senl_19, CD22 CAR-T, Senl_22, CD19+CD22 CAR-T, Senl_19+22, Fludarabine, fiu, Cyclophosphamide, ctx
Hebei Senlang Biotechnology Inc., Ltd.
Adult B Acute Lymphoblastic Leukemia
05/23
05/23

Download Options